Structure and Function of VLA Integrins: Differential Expression in B-Cell Leukemia/Lymphoma

References

• Hemler M.E., Sanchez-Madrid F., Flotte T.J., Krensky A.M., Burakoff S.J., Bhan A.K., Springer T.A., Strominger J.L. Glycoprotein of 210 000 and 130 000 m.w. on activated T cell: cell distribution and antigenic relation to component on resting cells and T-cell lines. J. Immunol. 1984; 132: 3011–3018
   PubMed Web of Science ®Google Scholar
• Patarroyo M., Prieto J., Rincon J., Timonen T., Lundberg C., Lindbom L., Asjo B., Gahmberg C.G. Leucocyte cell adhesion: A molecular process fundamental in leukocyte physiology. Immunol. Rev. 1990; 114: 67–108
   PubMed Web of Science ®Google Scholar
• Arnout M. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75: 1037–1050
   PubMed Web of Science ®Google Scholar
• Baldini L., Cro L., Calori R., Nobili L., Silvestris I., Maiolo A.T. Blood 1992; 79: 2688–2693
   PubMed Web of Science ®Google Scholar
• Kajiiji S., Tamura R.N., Quaranta V. A novel integrin (alphaE beta4) from human epithelial cells suggest a fourth family of integrin adhesion receptor. EMBO J. 1989; 8: 673–680
   PubMed Web of Science ®Google Scholar
• Hemler M.E., Crouse C., Sonnenberg A. Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA β 1 subunits on certain cell lines. J. Biol. Chem. 1989; 264: 6529–6535
   PubMed Web of Science ®Google Scholar
• Cheresh D.A., Smith J.W., Cooper H.M., Quaranta V. A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell 1989; 57: 59–69
   PubMed Web of Science ®Google Scholar
• Holzmann B., Weismann I.L. Peyer's Patch specific lymphocyte homing receptors consist of a VLA-4-like alpha chain associated with either of two integrin beta chains, one of which is novel. EMBO J. 1989; 8: 1735–1741
   PubMed Web of Science ®Google Scholar
• Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11–25
   PubMed Web of Science ®Google Scholar
• Pierschbacher E.M. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491–497
   PubMed Web of Science ®Google Scholar
• Larson R.S., Springer T.A. Structure and function of leukocyte integrins. Immunol. Rev. 1990; 114: 181–217
   PubMed Web of Science ®Google Scholar
• Hemler M.E., Elices M.J., Parker C., Takada Y. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol. Rev. 1990; 114: 45–65
   PubMed Web of Science ®Google Scholar
• Pulido R., Elices M.J., Campanero M.R., Osborn L., Schiffer S., Garcia-Pardo A., Lobb R., Hemler M.E., Sanchez-Madrid F. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J. Biol. Chem. 1991; 166: 10241–10245
   Google Scholar
• Carter G.W., Ryan M.C., Gahr P. Epiligrin, a new cell adhesion ligand for integrin alpha3betal in epithelial basement membranes. Cell 1991; 65: 599–610
   PubMed Web of Science ®Google Scholar
• Lemoine F.M., Dedhar S., Lima G.M., Eaves C.J. Transformation-associated alterations in interactions between pre-B cells and fibronectin. Blood 1990; 11: 2311–2320
   Google Scholar
• Dang N.H., Torimoto Y., Schlossman S.F., Mori-Moto C. Human CD4 helper T cell activation: functional involvement with two distinct collagen receptors, IF7 and VLA integrin family. J. Exp. Med. 1990; 172: 649–652
   PubMed Web of Science ®Google Scholar
• Lever W.F., Schaumburg-Lever G. Histopathology of the Skin, 7th edn. Lippincott Company, Philadelphia 1990
   Google Scholar
• Yamada A., Nojima Y., Suguta K., Dang N.H., Schlossman S.F., Morimoto C. Cross-linking of VLA/CD29 molecule has co-mitogenic effect with anti CD3 on CD4 cell activation in serum-free culture system. Eur. J. Immunol. 1991; 21: 319–325
   PubMed Web of Science ®Google Scholar
• Wayner E.A., Carter W., Piotrowicz R.S., Kunicki T.J. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoprotein Ic-Ha. J. Cell Biol. 1988; 107: 1881–1891
   PubMed Web of Science ®Google Scholar
• Wayner E.A., Garcia-Pardo A., Humphries M.J., McDonald J.A., Carter W. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 1989; 109: 1321–1330
   PubMed Web of Science ®Google Scholar
• Klingemann H.G., Dedhar S. Distribution of integrins on human peripheral blood mononuclear cells. Blood 1989; 74: 1348–1354
   PubMed Web of Science ®Google Scholar
• Zutter M.M. Immunolocalization of integrin receptors in normal lymphoid system. Blood 1991; 10: 2231–2236
   Google Scholar
• Humphries M.J., Olden K., Yamada K.M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233: 467–470
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Bergui L., Schena M., Chilosi M., Marchisio P.C. Cell-cell and cell-matrix adhesion structures may influence the growth pattern of chronic lymphoid malignancies. Leukemia 1989; 3: 167–169
   PubMed Web of Science ®Google Scholar
• Inghirami G., Wieczorek R., Zhu B.Y., Silber R., Favera DallaR. Differential expression of LFA-1 molecules in Non-Hodgkin's Lymphoma and lymphoid leukemia. Blood 1988; 4: 1431–1434
   Google Scholar
• Patarroyo M., Prieto J., Ernberg I., Gahmberg C.G. Absence or low expression of leukocyte adhesion molecule CD11 and CD18 on Burkitt's lymphoma. Int. J. Cancer 1988; 41: 901
   PubMed Web of Science ®Google Scholar
• Inghirami G., Grignani F., Sternas L., Lombardi L., Knowles D.M., Favera DallaR. Down-regulation of LFA-1 adhesion receptors by c-myc oncogenes in human B lymphoblastoid cells. Science 1990; 250: 682–686
   PubMed Web of Science ®Google Scholar
• Moller P., Eichelmann A., Koretz K., Mechtersheimer G. Adhesion molecules VLA-1 to VLA-6 define discrete stages of peripheral B lymphocyte development and characterize different types of B cell neoplasia. Leukemia 1992; 6: 256–264
   PubMed Web of Science ®Google Scholar
• Baldini L., Cro L., Cortelezzi A., Calori R., Nobili L., Maiolo A.T., Polli E.E. Cancer 1990; 66: 1738–1742
   PubMed Web of Science ®Google Scholar